AFP 2012-05-11 15:45:40 -
This handout picture released by Gilead Sciences Europe Ltd on May 11, 2012 shows a box and tablets of antiretroviral drug Truvada displayed on a table. The U.S. Food and Drug Administration (FDA) Antiviral Drugs Advisory Committee approved Gilead Sciences' Truvada as a preventative treatment for people who are at high risk of contracting HIV through sexual intercourse on May 10, 2012. Already approved to treat people infected with HIV, Truvada would be a milestone in the worldwide AIDS epidemic by offering a tablet capable of preventing infection in high-risk individuals.
RESTRICTED TO EDITORIAL USE - MANDATORY CREDIT "AFP PHOTO / Gilead Sciences Europe Ltd" - NO MARKETING NO ADVERTISING CAMPAIGNS - DISTRIBUTED AS A SERVICE TO CLIENTS